U.S. Clinical Trial of MicroVention’s New Dual-Layer Stent For Cerebral Aneurysm Flow Diversion

MicroVention Announces First Trial Enrollment In Their U.S. Clinical Trial Of Its New Dual-Layer Stent For Cerebral Aneurysm Flow Diversion (via PR Newswire)

TUSTIN, Calif., July 22, 2013 /PRNewswire/ — MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced earlier last week that they successfully completed their first enrollment in a multi-center, prospective, pivotal U.S. clinical…